Legal & General Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-250,669
Closed -$3.86M 3379
2025
Q4
$3.86M Sell
250,669
-5,648
-2% -$62.2K ﹤0.01% 1697
2025
Q3
$2.55M Sell
256,317
-27,354
-10% -$285K ﹤0.01% 1880
2025
Q2
$2.81M Sell
283,671
-43,136
-13% -$455K ﹤0.01% 1824
2025
Q1
$4.24M Sell
326,807
-19,503
-6% -$258K ﹤0.01% 1602
2024
Q4
$4.42M Sell
346,310
-4,182
-1% -$50.6K ﹤0.01% 1638
2024
Q3
$3.9M Sell
350,492
-18,373
-5% -$203K ﹤0.01% 1688
2024
Q2
$4.14M Buy
368,865
+2,706
+0.7% +$31.5K ﹤0.01% 1616
2024
Q1
$4.54M Sell
366,159
-320
-0.1% -$4.17K ﹤0.01% 1567
2023
Q4
$5.12M Buy
366,479
+2,501
+0.7% +$34.7K ﹤0.01% 1491
2023
Q3
$5.38M Buy
363,978
+19,224
+6% +$270K ﹤0.01% 1400
2023
Q2
$4.45M Buy
344,754
+47,097
+16% +$537K ﹤0.01% 1520
2023
Q1
$2.92M Sell
297,657
-696
-0.2% -$7.43K ﹤0.01% 1701
2022
Q4
$3.17M Buy
298,353
+8,715
+3% +$101K ﹤0.01% 1652
2022
Q3
$3.02M Sell
289,638
-6,120
-2% -$79.7K ﹤0.01% 1643
2022
Q2
$3.72M Buy
295,758
+238,178
+414% +$2.53M ﹤0.01% 1569
2022
Q1
$624K Buy
57,580
+1,506
+3% +$18.3K ﹤0.01% 2337
2021
Q4
$789K Buy
56,074
+123
+0.2% +$2.02K ﹤0.01% 2297
2021
Q3
$1.07M Buy
55,951
+24,469
+78% +$325K ﹤0.01% 2227
2021
Q2
$310K Buy
31,482
+298
+1% +$2.71K ﹤0.01% 2429
2021
Q1
$306K Sell
31,184
-13,288
-30% -$110K ﹤0.01% 2375
2020
Q4
$198K Buy
44,472
+25,458
+134% +$115K ﹤0.01% 2421
2020
Q3
$83K Sell
19,014
-2,076
-10% -$14.8K ﹤0.01% 2537
2020
Q2
$187K Buy
21,090
+3,834
+22% +$19.4K ﹤0.01% 2373
2020
Q1
$61K Sell
17,256
-3,979
-19% -$18.4K ﹤0.01% 2537
2019
Q4
$121K Buy
21,235
+2,786
+15% +$14.9K ﹤0.01% 2536
2019
Q3
$66K Buy
18,449
+6,635
+56% +$25.7K ﹤0.01% 2651
2019
Q2
$47K Hold
11,814
﹤0.01% 2798
2019
Q1
$86K Hold
11,814
﹤0.01% 2536
2018
Q4
$108K Buy
11,814
+1,860
+19% +$20.6K ﹤0.01% 2434
2018
Q3
$123K Hold
9,954
﹤0.01% 2457
2018
Q2
$152K Sell
9,954
-1,288
-11% -$22.3K ﹤0.01% 2361
2018
Q1
$223K Sell
11,242
-3,978
-26% -$68.7K ﹤0.01% 2277
2017
Q4
$287K Sell
15,220
-1,793
-11% -$36K ﹤0.01% 2219
2017
Q3
$365K Buy
17,013
+4,512
+36% +$71.4K ﹤0.01% 2160
2017
Q2
$121K Buy
12,501
+1,950
+18% +$12.7K ﹤0.01% 2501
2017
Q1
$62K Hold
10,551
﹤0.01% 2793
2016
Q4
$43K Buy
10,551
+4,780
+83% +$35K ﹤0.01% 2921
2016
Q3
$59K Sell
5,771
-464
-7% -$6.67K ﹤0.01% 2438
2016
Q2
$89K Hold
6,235
﹤0.01% 2158
2016
Q1
$117K Buy
6,235
+1,003
+19% +$20.3K ﹤0.01% 1963
2015
Q4
$125K Hold
5,232
﹤0.01% 1946
2015
Q3
$126K Hold
5,232
﹤0.01% 1908
2015
Q2
$116K Hold
5,232
﹤0.01% 2015
2015
Q1
$121K Hold
5,232
﹤0.01% 1913
2014
Q4
$90K Sell
5,232
-1
-0% -$15 ﹤0.01% 2062
2014
Q3
$77K Buy
+5,233
New +$75.4K ﹤0.01% 2094

Other funds holding DVAX

Legal & General Group's DVAX Position: Q1 2026 in Review

Legal & General Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 250,669 shares — an estimated $3.86M sold.

Legal & General Group first reported a position in DVAX in Q3 2014 and held it in 46 quarters. The position peaked at $5.38M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Legal & General Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Legal & General Group sold 250,669 Dynavax Technologies shares in Q1 2026, an estimated $3.86M.
  • Legal & General Group first reported a position in Dynavax Technologies in Q3 2014 and held it in 46 quarters.
  • Legal & General Group's Dynavax Technologies position peaked at $5.38M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.